+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Hyperhomocysteinemia and vascular access thrombosis in chronic hemodialysis Is there an association?



Hyperhomocysteinemia and vascular access thrombosis in chronic hemodialysis Is there an association?



Journal of the American Society of Nephrology 11(Program and Abstract Issue): 282A




(PDF emailed within 1 workday: $29.90)

Accession: 035060552

Download citation: RISBibTeXText


Related references

No association between hyperhomocysteinemia and vascular access thrombosis in chronic hemodialysis. Journal of Vascular Access 4(1): 14-20, 2003

Hyperhomocysteinemia and vascular access thrombosis in hemodialysis patients: a retrospective study. Vascular Health and Risk Management 9: 361-364, 2013

Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients. Kidney International 55(1): 315-320, 1999

Role of the hyperhomocysteinemia and coagulation-fibrinolytic system activity status in vascular access thrombosis in hemodialysis patients. Nephrology Dialysis Transplantation 15(9): A190, 2000

IgM-anticardiolipin antibody and vascular access thrombosis in chronic hemodialysis patients. Renal Failure 27(1): 25-30, 2005

Association Between Thrombophilic Gene Mutations and the Risk of Vascular Access Thrombosis in Hemodialysis Patients. Therapeutic Apheresis and Dialysis 20(2): 107-111, 2017

Role of thrombophilia in vascular access thrombosis among chronic hemodialysis patients in Tunisia. Therapeutic Apheresis and Dialysis 15(1): 40-43, 2011

Atrial fibrillation linked to vascular access thrombosis in chronic hemodialysis patients. Journal of Atherosclerosis and Thrombosis 18(6): 448-453, 2011

Vascular access thrombosis is not related to presence of antiphospholipid antibodies in patients on chronic hemodialysis. Nephron 92(4): 957-958, 2002

Hyperhomocysteinaemia and vascular access thrombosis among chronic hemodialysis patients in Taiwan: a retrospective study. International Journal of Clinical Practice 60(12): 1596-1599, 2006

Use of enoxaparin to diminish the incidence of vascular access stenosis/thrombosis in chronic hemodialysis patients. International Urology and Nephrology 43(2): 499-505, 2011

The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis. Thrombosis Research 120(2): 215-220, 2006

Recombinant streptokinase treatment of thrombosis of the permanent vascular access in chronic renal insufficiency patients treated with periodic hemodialysis. Biotecnologia Aplicada 12(3): 195-196, 1995

Thombotic events in vascular access of hemodialysis patients and the correlation with hyperhomocysteinemia, lipids and oxidative stress. Nephrology Dialysis Transplantation 17(Abstracts Supplement 1): 284, 2002

Hyperhomocysteinemia and levels of lipoprotein are inversely related to failure of vascular access in patients on maintenance hemodialysis. Journal of the American Society of Nephrology 9(PROGRAM AND ABSTR ISSUE): 252A-253A, Sept, 1997